1h Free Analyst Time
The point-of-care testing (POCT) market in US is forecasted to grow by USD 10.21 billion during 2023-2028, accelerating at a CAGR of 9.45% during the forecast period. The report on the point-of-care testing (POCT) market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, rising awareness regarding portable and low-cost self-testing devices, and rising number of clia-waived POCT.
The point-of-care testing (POCT) market in US is segmented as below:
By Type
- OTC testing
- Prescription-based testing
By Application
- Blood glucose testing
- Infectious diseases testing
- Cardiac markers testing
- Pregnancy and fertility testing
- Others
By Geographical Landscape
- North America
The report on the point-of-care testing (POCT) market in US covers the following areas:
- Point-of-care testing (POCT) market in US sizing
- Point-of-care testing (POCT) market in US forecast
- Point-of-care testing (POCT) market in US industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the point-of-care testing (POCT) market in US: Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., Bio RAD Laboratories Inc., Boditech Med Inc., Cardinal Health Inc., Chembio Diagnostics Inc., Danaher Corp., ELITechGroup SAS, F. Hoffmann La Roche Ltd., Heska Corp., iAssay Inc., Johnson and Johnson Services Inc., Nova Biomedical Corp., OraSure Technologies Inc., Phamatech Inc., Princeton BioMeditech Corp., Quest Diagnostics Inc., QuidelOrtho Corp., Sekisui Chemical Co. Ltd., Trivida Health Inc., and Zoetis Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advancements in POCT devices."
According to the report, one of the major drivers for this market is the growing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- ACON Laboratories Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Boditech Med Inc.
- Cardinal Health Inc.
- Chembio Diagnostics Inc.
- Danaher Corp.
- ELITechGroup SAS
- F. Hoffmann La Roche Ltd.
- Heska Corp.
- iAssay Inc.
- Johnson and Johnson Services Inc.
- Nova Biomedical Corp.
- OraSure Technologies Inc.
- Phamatech Inc.
- Princeton BioMeditech Corp.
- Quest Diagnostics Inc.
- QuidelOrtho Corp.
- Sekisui Chemical Co. Ltd.
- Trivida Health Inc.
- Zoetis Inc.
